▶ 調査レポート

世界のレジオネラ症検査市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Legionnaire Disease Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のレジオネラ症検査市場 2021:企業別、地域別、種類・用途別 / Global Legionnaire Disease Testing Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12426資料のイメージです。• レポートコード:GIR-107A12426
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、108ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、レジオネラ症検査のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。レジオネラ症検査の種類別市場規模(尿中抗原検査、直接蛍光抗体(DFA)染色、併用検査(培養・尿中抗原検査)、その他)、用途別市場規模(病院、診断研究所、研究センター、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・レジオネラ症検査の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Danaher、Bio-Rad、Abbott、Roche、Thermo Fischer Scientific、BD、Aquacert、BioMérieux、Idexx、Albagaia
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:尿中抗原検査、直接蛍光抗体(DFA)染色、併用検査(培養・尿中抗原検査)、その他
・用途別分析2016年-2026年:病院、診断研究所、研究センター、その他
・レジオネラ症検査の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・レジオネラ症検査のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・レジオネラ症検査のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・レジオネラ症検査の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・レジオネラ症検査の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Legionnaire Disease Testing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Legionnaire Disease Testing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Legionnaire Disease Testing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Legionnaire Disease Testing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Urinary Antigen Testing
Direct Fluorescent Antibody (DFA) Stain
Combination Testing (Culture and Urinary Antigen Testing)
Others

Market segment by Application, can be divided into
Hospitals
Diagnostic Laboratories
Research Centers
Others

Market segment by players, this report covers
Danaher
Bio-Rad
Abbott
Roche
Thermo Fischer Scientific
BD
Aquacert
BioMérieux
Idexx
Albagaia

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Legionnaire Disease Testing
1.2 Classification of Legionnaire Disease Testing by Type
1.2.1 Overview: Global Legionnaire Disease Testing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Legionnaire Disease Testing Revenue Market Share by Type in 2020
1.2.3 Urinary Antigen Testing
1.2.4 Direct Fluorescent Antibody (DFA) Stain
1.2.5 Combination Testing (Culture and Urinary Antigen Testing)
1.2.6 Others
1.3 Global Legionnaire Disease Testing Market by Application
1.3.1 Overview: Global Legionnaire Disease Testing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Centers
1.3.5 Others
1.4 Global Legionnaire Disease Testing Market Size & Forecast
1.5 Global Legionnaire Disease Testing Market Size and Forecast by Region
1.5.1 Global Legionnaire Disease Testing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Legionnaire Disease Testing Market Size by Region, (2016-2021)
1.5.3 North America Legionnaire Disease Testing Market Size and Prospect (2016-2026)
1.5.4 Europe Legionnaire Disease Testing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Legionnaire Disease Testing Market Size and Prospect (2016-2026)
1.5.6 South America Legionnaire Disease Testing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Legionnaire Disease Testing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Legionnaire Disease Testing Market Drivers
1.6.2 Legionnaire Disease Testing Market Restraints
1.6.3 Legionnaire Disease Testing Trends Analysis
2 Company Profiles
2.1 Danaher
2.1.1 Danaher Details
2.1.2 Danaher Major Business
2.1.3 Danaher Legionnaire Disease Testing Product and Solutions
2.1.4 Danaher Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Danaher Recent Developments and Future Plans
2.2 Bio-Rad
2.2.1 Bio-Rad Details
2.2.2 Bio-Rad Major Business
2.2.3 Bio-Rad Legionnaire Disease Testing Product and Solutions
2.2.4 Bio-Rad Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Bio-Rad Recent Developments and Future Plans
2.3 Abbott
2.3.1 Abbott Details
2.3.2 Abbott Major Business
2.3.3 Abbott Legionnaire Disease Testing Product and Solutions
2.3.4 Abbott Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Abbott Recent Developments and Future Plans
2.4 Roche
2.4.1 Roche Details
2.4.2 Roche Major Business
2.4.3 Roche Legionnaire Disease Testing Product and Solutions
2.4.4 Roche Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Roche Recent Developments and Future Plans
2.5 Thermo Fischer Scientific
2.5.1 Thermo Fischer Scientific Details
2.5.2 Thermo Fischer Scientific Major Business
2.5.3 Thermo Fischer Scientific Legionnaire Disease Testing Product and Solutions
2.5.4 Thermo Fischer Scientific Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Thermo Fischer Scientific Recent Developments and Future Plans
2.6 BD
2.6.1 BD Details
2.6.2 BD Major Business
2.6.3 BD Legionnaire Disease Testing Product and Solutions
2.6.4 BD Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 BD Recent Developments and Future Plans
2.7 Aquacert
2.7.1 Aquacert Details
2.7.2 Aquacert Major Business
2.7.3 Aquacert Legionnaire Disease Testing Product and Solutions
2.7.4 Aquacert Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Aquacert Recent Developments and Future Plans
2.8 BioMérieux
2.8.1 BioMérieux Details
2.8.2 BioMérieux Major Business
2.8.3 BioMérieux Legionnaire Disease Testing Product and Solutions
2.8.4 BioMérieux Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 BioMérieux Recent Developments and Future Plans
2.9 Idexx
2.9.1 Idexx Details
2.9.2 Idexx Major Business
2.9.3 Idexx Legionnaire Disease Testing Product and Solutions
2.9.4 Idexx Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Idexx Recent Developments and Future Plans
2.10 Albagaia
2.10.1 Albagaia Details
2.10.2 Albagaia Major Business
2.10.3 Albagaia Legionnaire Disease Testing Product and Solutions
2.10.4 Albagaia Legionnaire Disease Testing Revenue, Gross Margin and Market Share (2019-2021)
2.10.5 Albagaia Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Legionnaire Disease Testing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Legionnaire Disease Testing Players Market Share
3.2.2 Top 10 Legionnaire Disease Testing Players Market Share
3.2.3 Market Competition Trend
3.3 Legionnaire Disease Testing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Legionnaire Disease Testing Revenue and Market Share by Type (2016-2021)
4.2 Global Legionnaire Disease Testing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Legionnaire Disease Testing Revenue Market Share by Application (2016-2021)
5.2 Legionnaire Disease Testing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Legionnaire Disease Testing Revenue by Type (2016-2026)
6.2 North America Legionnaire Disease Testing Revenue by Application (2016-2026)
6.3 North America Legionnaire Disease Testing Market Size by Country
6.3.1 North America Legionnaire Disease Testing Revenue by Country (2016-2026)
6.3.2 United States Legionnaire Disease Testing Market Size and Forecast (2016-2026)
6.3.3 Canada Legionnaire Disease Testing Market Size and Forecast (2016-2026)
6.3.4 Mexico Legionnaire Disease Testing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Legionnaire Disease Testing Revenue by Type (2016-2026)
7.2 Europe Legionnaire Disease Testing Revenue by Application (2016-2026)
7.3 Europe Legionnaire Disease Testing Market Size by Country
7.3.1 Europe Legionnaire Disease Testing Revenue by Country (2016-2026)
7.3.2 Germany Legionnaire Disease Testing Market Size and Forecast (2016-2026)
7.3.3 France Legionnaire Disease Testing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Legionnaire Disease Testing Market Size and Forecast (2016-2026)
7.3.5 Russia Legionnaire Disease Testing Market Size and Forecast (2016-2026)
7.3.6 Italy Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Legionnaire Disease Testing Revenue by Type (2016-2026)
8.2 Asia-Pacific Legionnaire Disease Testing Revenue by Application (2016-2026)
8.3 Asia-Pacific Legionnaire Disease Testing Market Size by Region
8.3.1 Asia-Pacific Legionnaire Disease Testing Revenue by Region (2016-2026)
8.3.2 China Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8.3.3 Japan Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8.3.4 South Korea Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8.3.5 India Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Legionnaire Disease Testing Market Size and Forecast (2016-2026)
8.3.7 Australia Legionnaire Disease Testing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Legionnaire Disease Testing Revenue by Type (2016-2026)
9.2 South America Legionnaire Disease Testing Revenue by Application (2016-2026)
9.3 South America Legionnaire Disease Testing Market Size by Country
9.3.1 South America Legionnaire Disease Testing Revenue by Country (2016-2026)
9.3.2 Brazil Legionnaire Disease Testing Market Size and Forecast (2016-2026)
9.3.3 Argentina Legionnaire Disease Testing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Legionnaire Disease Testing Revenue by Type (2016-2026)
10.2 Middle East & Africa Legionnaire Disease Testing Revenue by Application (2016-2026)
10.3 Middle East & Africa Legionnaire Disease Testing Market Size by Country
10.3.1 Middle East & Africa Legionnaire Disease Testing Revenue by Country (2016-2026)
10.3.2 Turkey Legionnaire Disease Testing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Legionnaire Disease Testing Market Size and Forecast (2016-2026)
10.3.4 UAE Legionnaire Disease Testing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Legionnaire Disease Testing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Legionnaire Disease Testing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Legionnaire Disease Testing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Legionnaire Disease Testing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Legionnaire Disease Testing Revenue Market Share by Region (2021-2026)
Table 6. Danaher Corporate Information, Head Office, and Major Competitors
Table 7. Danaher Major Business
Table 8. Danaher Legionnaire Disease Testing Product and Solutions
Table 9. Danaher Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Bio-Rad Corporate Information, Head Office, and Major Competitors
Table 11. Bio-Rad Major Business
Table 12. Bio-Rad Legionnaire Disease Testing Product and Solutions
Table 13. Bio-Rad Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Abbott Corporate Information, Head Office, and Major Competitors
Table 15. Abbott Major Business
Table 16. Abbott Legionnaire Disease Testing Product and Solutions
Table 17. Abbott Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Roche Corporate Information, Head Office, and Major Competitors
Table 19. Roche Major Business
Table 20. Roche Legionnaire Disease Testing Product and Solutions
Table 21. Roche Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Thermo Fischer Scientific Corporate Information, Head Office, and Major Competitors
Table 23. Thermo Fischer Scientific Major Business
Table 24. Thermo Fischer Scientific Legionnaire Disease Testing Product and Solutions
Table 25. Thermo Fischer Scientific Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. BD Corporate Information, Head Office, and Major Competitors
Table 27. BD Major Business
Table 28. BD Legionnaire Disease Testing Product and Solutions
Table 29. BD Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Aquacert Corporate Information, Head Office, and Major Competitors
Table 31. Aquacert Major Business
Table 32. Aquacert Legionnaire Disease Testing Product and Solutions
Table 33. Aquacert Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. BioMérieux Corporate Information, Head Office, and Major Competitors
Table 35. BioMérieux Major Business
Table 36. BioMérieux Legionnaire Disease Testing Product and Solutions
Table 37. BioMérieux Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Idexx Corporate Information, Head Office, and Major Competitors
Table 39. Idexx Major Business
Table 40. Idexx Legionnaire Disease Testing Product and Solutions
Table 41. Idexx Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Albagaia Corporate Information, Head Office, and Major Competitors
Table 43. Albagaia Major Business
Table 44. Albagaia Legionnaire Disease Testing Product and Solutions
Table 45. Albagaia Legionnaire Disease Testing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 46. Global Legionnaire Disease Testing Revenue (USD Million) by Players (2019-2021)
Table 47. Global Legionnaire Disease Testing Revenue Share by Players (2019-2021)
Table 48. Breakdown of Legionnaire Disease Testing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 49. Legionnaire Disease Testing Players Head Office, Products and Services Provided
Table 50. Legionnaire Disease Testing Mergers & Acquisitions in the Past Five Years
Table 51. Legionnaire Disease Testing New Entrants and Expansion Plans
Table 52. Global Legionnaire Disease Testing Revenue (USD Million) by Type (2016-2021)
Table 53. Global Legionnaire Disease Testing Revenue Share by Type (2016-2021)
Table 54. Global Legionnaire Disease Testing Revenue Forecast by Type (2021-2026)
Table 55. Global Legionnaire Disease Testing Revenue by Application (2016-2021)
Table 56. Global Legionnaire Disease Testing Revenue Forecast by Application (2021-2026)
Table 57. North America Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 58. North America Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 59. North America Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 60. North America Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 61. North America Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 62. North America Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 63. Europe Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 64. Europe Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 65. Europe Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 66. Europe Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 67. Europe Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 68. Europe Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 69. Asia-Pacific Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 70. Asia-Pacific Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 71. Asia-Pacific Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 72. Asia-Pacific Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 73. Asia-Pacific Legionnaire Disease Testing Revenue by Region (2016-2021) & (USD Million)
Table 74. Asia-Pacific Legionnaire Disease Testing Revenue by Region (2021-2026) & (USD Million)
Table 75. South America Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 76. South America Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 77. South America Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 78. South America Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 79. South America Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 80. South America Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)
Table 81. Middle East & Africa Legionnaire Disease Testing Revenue by Type (2016-2021) & (USD Million)
Table 82. Middle East & Africa Legionnaire Disease Testing Revenue by Type (2021-2026) & (USD Million)
Table 83. Middle East & Africa Legionnaire Disease Testing Revenue by Application (2016-2021) & (USD Million)
Table 84. Middle East & Africa Legionnaire Disease Testing Revenue by Application (2021-2026) & (USD Million)
Table 85. Middle East & Africa Legionnaire Disease Testing Revenue by Country (2016-2021) & (USD Million)
Table 86. Middle East & Africa Legionnaire Disease Testing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Legionnaire Disease Testing Picture
Figure 2. Global Legionnaire Disease Testing Revenue Market Share by Type in 2020
Figure 3. Urinary Antigen Testing
Figure 4. Direct Fluorescent Antibody (DFA) Stain
Figure 5. Combination Testing (Culture and Urinary Antigen Testing)
Figure 6. Others
Figure 7. Legionnaire Disease Testing Revenue Market Share by Application in 2020
Figure 8. Hospitals Picture
Figure 9. Diagnostic Laboratories Picture
Figure 10. Research Centers Picture
Figure 11. Others Picture
Figure 12. Global Legionnaire Disease Testing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 13. Global Legionnaire Disease Testing Revenue and Forecast (2016-2026) & (USD Million)
Figure 14. Global Legionnaire Disease Testing Revenue Market Share by Region (2016-2026)
Figure 15. Global Legionnaire Disease Testing Revenue Market Share by Region in 2020
Figure 16. North America Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 17. Europe Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Asia-Pacific Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. South America Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. Middle East and Africa Legionnaire Disease Testing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Legionnaire Disease Testing Market Drivers
Figure 22. Legionnaire Disease Testing Market Restraints
Figure 23. Legionnaire Disease Testing Market Trends
Figure 24. Danaher Recent Developments and Future Plans
Figure 25. Bio-Rad Recent Developments and Future Plans
Figure 26. Abbott Recent Developments and Future Plans
Figure 27. Roche Recent Developments and Future Plans
Figure 28. Thermo Fischer Scientific Recent Developments and Future Plans
Figure 29. BD Recent Developments and Future Plans
Figure 30. Aquacert Recent Developments and Future Plans
Figure 31. BioMérieux Recent Developments and Future Plans
Figure 32. Idexx Recent Developments and Future Plans
Figure 33. Albagaia Recent Developments and Future Plans
Figure 34. Global Legionnaire Disease Testing Revenue Share by Players in 2020
Figure 35. Legionnaire Disease Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Legionnaire Disease Testing Revenue Market Share in 2020
Figure 37. Global Top 10 Players Legionnaire Disease Testing Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Legionnaire Disease Testing Revenue Share by Type in 2020
Figure 40. Global Legionnaire Disease Testing Market Share Forecast by Type (2021-2026)
Figure 41. Global Legionnaire Disease Testing Revenue Share by Application in 2020
Figure 42. Global Legionnaire Disease Testing Market Share Forecast by Application (2021-2026)
Figure 43. North America Legionnaire Disease Testing Sales Market Share by Type (2016-2026)
Figure 44. North America Legionnaire Disease Testing Sales Market Share by Application (2016-2026)
Figure 45. North America Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)
Figure 46. United States Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Legionnaire Disease Testing Sales Market Share by Type (2016-2026)
Figure 50. Europe Legionnaire Disease Testing Sales Market Share by Application (2016-2026)
Figure 51. Europe Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)
Figure 52. Germany Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Legionnaire Disease Testing Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Legionnaire Disease Testing Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Legionnaire Disease Testing Revenue Market Share by Region (2016-2026)
Figure 60. China Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Legionnaire Disease Testing Sales Market Share by Type (2016-2026)
Figure 67. South America Legionnaire Disease Testing Sales Market Share by Application (2016-2026)
Figure 68. South America Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Legionnaire Disease Testing Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Legionnaire Disease Testing Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Legionnaire Disease Testing Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Legionnaire Disease Testing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source